MedTrace Logo

Myeloma Registry Platform (MYRIAM)

NCT03308474 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2200

Last updated 2026-01-27

No results posted yet for this study

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Multiple Myeloma in Germany.

Conditions

Interventions

OTHER

Routine care as per site standard.

Physician's choice according to patient's needs.

Sponsors & Collaborators

  • Deutsche Studiengruppe Multiples Myelom (DSMM)

    collaborator UNKNOWN

  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Hermann Einsele, Prof MD · Wuerzburg University Hospital

  • Monika Engelhardt, Prof MD · Universitätsklinikum Freiburg

  • Tobias Dechow, Prof MD · Onkologie Ravensburg

  • Wolfgang Knauf, Prof MD · Centrum für Hämatologie und Onkologie Bethanien

  • Norbert Marschner, MD · Praxis für interdisziplinäre Onkologie & Hämatologie

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-25
Primary Completion
2026-12-31
Completion
2028-12-31

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03308474 on ClinicalTrials.gov